Strata Skin Sciences, Inc.
SSKN
$1.42
-$0.05-3.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.83% | -2.34% | 45.92% | -117.88% | -1,984.85% |
| Total Depreciation and Amortization | -27.13% | 0.00% | -0.68% | -0.45% | -0.68% |
| Total Amortization of Deferred Charges | 2.56% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -335.68% | -21.98% | -92.60% | 14,864.00% | -121.74% |
| Change in Net Operating Assets | 183.75% | -480.75% | 69.87% | -63.55% | 153.97% |
| Cash from Operations | 96.70% | -252.91% | -178.24% | 332.78% | -151.10% |
| Capital Expenditure | -1,768.85% | 130.65% | 60.52% | -712.90% | 82.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,768.85% | 130.65% | 60.52% | -712.90% | 82.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 159.04% | -151.00% | -476.38% | -87.40% | 541.87% |